Advagene Biopharma Co., Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced basic loss per share was TWD 0.83 compared to TWD 0.72 a year ago. For the half year, operating loss was TWD 40.490 million compared to TWD 32.646 million a year ago. Net loss was TWD 39.835 million compared to TWD 31.759 million a year ago.